CBD or Cannabidiol is a chemical ingredient of the Hemp or Cannabis plant. As the second most prevalent of the active ingredients of cannabis or Hemp plant. It has attracted a high degree of interest as a therapy in the last few years for a series of neuropsychiatric conditions. This non-psychoactive ingredient has a wide variety of possible healing and medical properties. For several years, CBD has been attracting much interest from people regarding its potential beneficial effects on the nervous system. We’re discovering through early research and (more research is needed) that CBD could potentially help people deal with epilepsy, several sclerosis, and nerve discomfort. Likewise, there’s the capacity for dealing with an array of neuropsychiatric problems, from injury and Anxiety to stress, Depression, and Panic attacks. The present evaluation aims to identify how CBD functions as a therapy for anxiety related ailments by examining results from preclinical, human speculative, medical, and epidemiological research studies. Recent research and studies such as http://journals.sagepub.com/doi/abs/10.1177/0269881110379283 in the Journal of Psychopharmacology, https://pubmed.ncbi.nlm.nih.gov/24923339/, and https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5101100/ show tremendous promise in preclinical trials. These research point to potential evidence that high sustainable use of CBD could be therapeutic for general anxiety conditions, such as panic attacks, social stress, obsessive-compulsive illness, and trauma. However, more research is needed. The general, existing proof only comes from anecdotal evidence from current CBD users.

Resources and Studies

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5101100/

https://pubmed.ncbi.nlm.nih.gov/24923339/

http://journals.sagepub.com/doi/abs/10.1177/0269881110379283